Stock BHC BAUSCH HEALTH COMPANIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Bausch Health Companies Inc. Toronto S.E.

Equities

BHC

CA0717341071

Delayed Toronto S.E.
Other stock markets
 01:37:03 2024-04-16 pm EDT 		5-day change 1st Jan Change
11.87 CAD -0.17% Intraday chart for Bausch Health Companies Inc. -5.34% +11.67%
Apr. 12 Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says MT
Apr. 12 RBC Notes "Positive" Appellate Court Ruling For Bausch Health, But Thinks Market Assigning ~32% BLCO Distribution Odds MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says
MT
RBC Notes "Positive" Appellate Court Ruling For Bausch Health, But Thinks Market Assigning ~32% BLCO Distribution Odds
MT
Bausch Health, Canada Inc. - Acne vulgaris treatment PrARAZLO now available to patients through British Columbia PharmaCare public drug plan
AQ
Bausch Health Companies - Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029
AQ
Bausch Health to Announce First-Quarter 2024 Results on May 2
AQ
Bausch wins US appeal to block Alvogen generic of diarrhea drug
RE
Canadian Investment Regulatory Organization Trade Resumption - BHC
AQ
Canadian Investment Regulatory Organization Trading Halt - BHC
AQ
Bausch Health, Canada Inc. Announces Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
CI
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision
RE
Bausch Health Up Near 0.4% In US Premarket After Announcing Patent Lawsuit Against Amneal Pharmaceuticals
MT
North American Morning Briefing : Inflation Data, -2-
DJ
Trump eyes $43 million haul from biggest fundraiser yet
RE
RBC Raises Bausch Health Target to US$12, Maintains Sector Perform, on Upcoming Xifaxan Litigation Ruling
MT
RBC Ups PT on Bausch Health Companies to $12 From $9 Reflecting Upcoming Appellate Court Decisions & Potential BLCO Distribution, Maintains Sector Perform Rating
MT
/C O R R E C T I O N from Source -- Canadian Investment Regulatory Organization (CIRO) - Halts/Resumptions/
AQ
Canadian Investment Regulatory Organization Trade Resumption - BHC
AQ
Bausch Health - Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
AQ
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for Uceris Aerosol Foam
MT
Bausch Health Brief: Bausch Health, Canada Inc. Announcing First Public Drug Plan Listings for UCERIS Aerosol Foam
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BHC Stock
  4. BHC Stock
  5. News Bausch Health Companies Inc.